Richard Barry

Insider Reports History

Entity
Individual
Location
285 Margalita Drive, San Rafael, CA
Signature
/s/ Eric J. Schoen by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Barry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. Director Common Stock 2.93M $367M $125.34 Mar 1, 2024 Direct
Sarepta Therapeutics, Inc. Director Common Stock 240K $30.1M $125.34 Mar 1, 2024 By Trust
CASSAVA SCIENCES INC President & CEO, Director Common Stock 470K $10.3M $22.00 Apr 23, 2024 By Trust
CASSAVA SCIENCES INC President & CEO, Director Stock Option (Right to Buy) 600K $10.1M $16.87 Oct 1, 2024 Direct
Sarepta Therapeutics, Inc. Director Common Stock 10K $1.25M $125.34 Mar 1, 2024 By LLC
Sarepta Therapeutics, Inc. Director Stock Option (right to buy) 3.68K Mar 1, 2024 Direct
CASSAVA SCIENCES INC President & CEO, Director Common Stock Warrant 0 Apr 23, 2024 By Trust

Insider Reports Filed by Richard Barry

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SAVA CASSAVA SCIENCES INC Oct 1, 2024 1 $0 4 Oct 1, 2024 President & CEO, Director
SAVA CASSAVA SCIENCES INC May 9, 2024 1 $0 4 May 13, 2024 Director
SAVA CASSAVA SCIENCES INC Apr 23, 2024 3 $3.87M 4 Apr 25, 2024 Director
SRPT Sarepta Therapeutics, Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 Director
SRPT Sarepta Therapeutics, Inc. Nov 3, 2023 2 $3.94M 4 Nov 6, 2023 Director
SAVA CASSAVA SCIENCES INC Aug 21, 2023 2 $308K 4 Aug 23, 2023 Director
SAVA CASSAVA SCIENCES INC May 4, 2023 2 $559K 4 May 8, 2023 Director
SRPT Sarepta Therapeutics, Inc. Mar 6, 2023 2 $0 4 Mar 8, 2023 Director
SAVA CASSAVA SCIENCES INC Mar 6, 2023 2 $2.29M 4 Mar 8, 2023 Director
SAVA CASSAVA SCIENCES INC Aug 23, 2022 1 $860K 4 Aug 25, 2022 Director
SRPT Sarepta Therapeutics, Inc. Mar 7, 2022 2 $0 4 Mar 8, 2022 Director
SAVA CASSAVA SCIENCES INC Jun 11, 2021 0 $0 3 Jun 14, 2021 Director